Submit Deal

CHEPLAPHARM ARZNEIMITTEL GBMH

Summary

CHEPLAPHARM Arzneimittel manufactures pharmaceutical products. The Company offers drugs, dietary supplements, medical devices, and cosmetics. CHEPLAPHARM Arzneimittel serves customers worldwide.

Deals Overview

Total Deals4

Valued Deals4

Total Value£ 1.13 B

Avg. Deal Size£ 283 M

Market Context

Senior Management

Sebastian F. Braun
CEO and Founder
Jens Rothstein
CFO
Jens Remmers
Head of Treasury & Investor Relations

Sort

takeda pharmaceutical company limited (prescription products)

HQ - Japan

Medical Supplies

5 Jan 2021

Investment Date

100%

Stake

£ 412 M

Deal Value

cheplapharm arzneimittel gbmh

HQ - Germany

Pharmaceuticals

25 Oct 2022

Investment Date

£ 479 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy